622 matches for your search in the start-up spotlight
rssNUCLIDIUM AG is a clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer. Leveraging copper isotopes – Copper-61 for diagnostics and Copper-67 for therapeutics – NUCLIDIUM is creating a ...
Neoclease is a biotechnology company pioneering AI-designed gene-editing therapies optimized for individual genes. Using a proprietary platform that integrates generative protein models with synthetic biology, Neoclease builds ultra-precise, delivery-ready nucleases for diseases with high unmet ...
Mosanna Therapeutics is a clinical-stage biotech company pioneering a novel pharmaceutical approach to treating obstructive sleep apnea (OSA) with an easily administered nasal spray. Designed to help restore the body’s natural airway control during sleep, Mosanna’s lead therapy, MOS118, offers a ...
SpliceBio is a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes. The Company’s lead program, SB-007, targets the root cause of Stargardt disease, a genetic eye disease that causes blindness in children and adults. ...
We are a spin-out from the Technical University of Munich, specialising in the clinical and commercial development of a proprietary oncolytic virus platform for cancer immunotherapy. Fusix Biotech GmbH is a Munich based start-up founded in 2022. The management team is comprised of the four ...
Visienco is a Swiss techbio company on a mission to make organoids clinically reliable at scale. Organoids, lab-grown mini-organs, are transforming how we understand human biology and test therapies. But their full potential is limited by manual, variable, and low-throughput workflows. At ...
For growers who want to get the best yield without wasting resources, NutriSen has developed the first biosensors test strips that can measure the amount of nitrate in plants directly in the field. Instead of indirect measurements such as chlorophyll content, NutriSen provides lab-accurate ...
The TQx platform will transform the traditional way of producing cellular therapies, which is often slow, expensive, and hard to scale, into a very fast and highly automated process right at the patient's side. This method uses extra-corporeal gene therapy but keeps the benefits of autologous ...
ReproNovo was founded in 2021 by a team with proven expertise in the reproductive medicine and women’s health space. With years of immersion in this field, we possess deep knowledge of drug development, regulatory affairs and business development in these therapeutic areas, the treatment ...
Azafaros is a clinical-stage company founded in 2018 with a deep understanding of rare genetic disease mechanisms using compound discoveries made by scientists at Leiden University and Amsterdam UMC and is led by a team of highly experienced industry experts. Azafaros aims to build a pipeline of ...